STOCK TITAN

Healthcare Risk and Compliance Executive Joins FTI Consulting as Senior Managing Director

(Neutral)
(Neutral)
Tags

FTI Consulting (NYSE:FCN) appointed healthcare risk and compliance expert Sean O'Reilly as Senior Managing Director in its Healthcare Risk Management & Advisory practice.

He brings 25+ years of experience in compliance program design, regulatory risk management and data-driven analytics across multiple healthcare sectors, including Medicare Advantage and Medicaid.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction – FCN

+0.78%
+0.78% Session close to close

In the Jun 9 session, FCN gained 0.78%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement adds a seasoned healthcare risk and compliance executive to FTI Consulting’s Healt...
Analysis

This announcement adds a seasoned healthcare risk and compliance executive to FTI Consulting’s Healthcare Risk Management & Advisory practice, reinforcing its focus on regulatory risk, analytics and fraud, waste and abuse mitigation. It follows other recent senior Managing Director appointments and a sizeable buyback authorization of $370.0 million. Investors monitoring the story may watch how this hire supports growth in healthcare engagements, complements the firm’s AI and analytics capabilities, and fits alongside ongoing capital return and governance trends.

Key Figures

Buyback authorization: $370.0 million Shares repurchased: 19.1 million shares Total buyback spend: $2.1 billion +5 more
8 metrics
Buyback authorization $370.0 million Additional stock repurchase authorization on June 3, 2026
Shares repurchased 19.1 million shares Total repurchased since 2016 under buyback program
Total buyback spend $2.1 billion Aggregate repurchase outlay since 2016
Buyback capacity $507.4 million Remaining under repurchase program after new authorization
SVP tax disposition 138 shares at $156.10 Tax-withholding disposition by director Elsy Lisa Boglioli on June 4, 2026
Restricted stock grant 1,616 shares Typical director restricted stock or unit grant vesting in one year
Deferred RSU grant 371 units Deferred Restricted Stock Units granted to director Laureen Seeger
Votes for pay proposal 26.7 million votes Support for 2025 executive compensation at 2026 annual meeting

Historical Context

5 past events · Latest: Jun 08 (Positive)
Pattern 5 events
Date Event Sentiment 24h Move Catalyst
Jun 08 AI expert affiliation Positive -0.7% Compass Lexecon affiliated with AI and machine learning expert Dennis Zhang.
Jun 05 Buyback authorization Positive +2.3% Board authorized an additional $370.0 million for stock repurchases.
Jun 04 AI value index Positive +0.9% Release of 2026 Private Equity Value Creation Index highlighting AI and M&A.
Jun 01 Senior MD appointment Positive +1.2% Appointment of Liz Lynch as Senior Managing Director in Corporate Reputation.
May 27 Transactions hire Positive +1.1% Appointment of Damon Yousefy as Senior Managing Director in Transactions practice.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent corporate developments and capital return news have generally coincided with modest positive price reactions, while one AI-related affiliation saw a small negative move.

Recent Company History

Over the past weeks, FTI Consulting has combined strategic hiring, capital returns and thematic thought leadership. The company added senior leaders such as Damon Yousefy and Liz Lynch as Senior Managing Directors in late May and early June 2026, each followed by gains of around 1%. An additional $370.0 million buyback authorization on June 3, 2026 saw a move of about 2.3%. AI-focused research and affiliations produced smaller, mixed reactions. Today’s healthcare risk and compliance hire continues this pattern of targeted senior talent additions.

Key Terms

medicare advantage, medicaid, value-based primary care, advanced analytics, +4 more
8 terms
medicare advantage medical
"including Medicare Advantage, Medicaid, employer group medical and specialty insurance"
Medicare Advantage is a type of health insurance plan offered by private companies that covers services traditionally provided by government-run Medicare. Think of it as a bundled package that combines hospital, doctor, and other medical care into one plan, often with added benefits. For investors, it matters because the popularity and profitability of these plans can influence healthcare companies and the broader health insurance industry.
medicaid medical
"including Medicare Advantage, Medicaid, employer group medical and specialty insurance"
Medicaid is a government-funded health insurance program that provides medical coverage to low-income individuals, families, elderly people and people with disabilities, administered jointly by the federal government and state governments in the United States. For investors, Medicaid matters because changes in eligibility, funding, or payment rules can alter patient volume and the prices hospitals, nursing homes, insurers and medical suppliers receive—similar to how a large customer or contract can shift a company’s revenue outlook.
value-based primary care medical
"home health, value-based primary care and pharmacy"
Value-based primary care is a way of organizing and paying for basic medical services that rewards keeping people healthy and avoiding costly emergency visits, rather than charging for each test or visit. For investors, it matters because it shifts how providers and insurers earn revenue—encouraging long-term patient relationships, cost savings, and predictable cash flow much like paying a car service to keep a vehicle running reliably instead of paying for every repair.
advanced analytics technical
"application of advanced analytics and artificial intelligence to identify and mitigate risk"
Advanced analytics involves using sophisticated techniques and tools to examine large amounts of data, uncover patterns, and generate insights that might not be obvious at first glance. For investors, it’s like using a high-powered microscope to see details that help predict future trends or make better decisions. This approach helps turn complex information into clear, actionable knowledge.
artificial intelligence technical
"advanced analytics and artificial intelligence to identify and mitigate risk"
Artificial intelligence is the ability of computers and machines to perform tasks that typically require human thinking, such as understanding language, recognizing patterns, or making decisions. For investors, it matters because AI can enhance efficiency, uncover new insights, and enable smarter strategies, potentially impacting the value and performance of companies that develop or utilize this technology.
natural language processing technical
"audit tools leveraging advanced data analytics and natural language processing to enhance"
Natural language processing is a technology that enables computers to understand, interpret, and respond to human language in a meaningful way. It allows machines to analyze large amounts of text, like news articles or social media posts, to identify patterns, trends, or sentiment. For investors, this means gaining faster insights from vast information sources, helping to inform smarter decisions in a rapidly changing world.
restricted stock units financial
"award of 1,616 shares of common stock in the form of restricted stock units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
deferred stock units financial
"two stock-based compensation grants in the form of deferred stock units"
Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

WASHINGTON, June 09, 2026 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced the appointment of former healthcare executive Sean O'Reilly as a Senior Managing Director in the firm’s Healthcare Risk Management & Advisory practice.

Mr. O’Reilly brings more than 25 years of experience advising healthcare organizations on compliance program design, regulatory risk management and operational integrity across a range of healthcare sectors, including Medicare Advantage, Medicaid, employer group medical and specialty insurance, military healthcare, hospice, home health, value-based primary care and pharmacy.

In his role at FTI Consulting, Mr. O’Reilly will advise clients on the design, implementation and improvement of enterprise compliance programs, focusing on risk identification, control development and regulatory responsiveness across managed care and provider organizations. He will also support clients with data-driven risk management, including the application of advanced analytics and artificial intelligence to identify and mitigate risk, including fraud, waste and abuse in healthcare.

“Healthcare compliance has never been more complex, and organizations are under increasing pressure to demonstrate that their compliance programs are both structurally sound and operationally embedded,” said Wayne Gibson, Leader of the Healthcare Risk Management & Advisory practice at FTI Consulting. “Sean brings a combination of in-house leadership, regulatory and compliance experience, and deep technical fluency in data and analytics that positions him to deliver exceptional value to our clients in a high-stakes regulatory environment.”

Prior to joining FTI Consulting, Mr. O’Reilly was the Senior Vice President and Chief Compliance Officer at a Fortune 50 Integrated healthcare company, where he implemented risk identification and remediation process improvements across managed care and clinical operations. He also directed the development of audit tools leveraging advanced data analytics and natural language processing to enhance the efficiency of compliance oversight across key risk domains. Earlier in his career, Mr. O’Reilly practiced as a medical malpractice and healthcare regulatory attorney.

Commenting on his appointment, Mr. O’Reilly said, "I have spent my career helping healthcare companies understand the risks and opportunities of operating in a dynamic, highly regulated industry. I look forward to continuing that work at FTI Consulting, leveraging our technological capabilities and the deep expertise of my colleagues to provide better outcomes for our clients and their members and patients.”

About FTI Consulting
FTI Consulting, Inc. is a leading global expert firm for organizations facing crisis and transformation, with more than 8,100 employees located in 32 countries and territories as of March 31, 2026. In certain jurisdictions, FTI Consulting’s services are provided through distinct legal entities that are separately capitalized and independently managed. The Company generated $3.8 billion in revenues during fiscal year 2025. More information can be found at www.fticonsulting.com.

FTI Consulting, Inc. 
555 12th Street NW 
Washington, DC 20004 
+1.202.312.9100

Investor Contact:  
Mollie Hawkes
+1.617.747.1791
mollie.hawkes@fticonsulting.com

Media Contact:  
Sam Ford
+1.617.480.7402
samantha.ford@fticonsulting.com


FAQ

Who is Sean O'Reilly, the new Senior Managing Director at FTI Consulting (NYSE:FCN)?

Sean O'Reilly is a healthcare risk and compliance executive with over 25 years of experience. According to FTI Consulting, he has advised organizations on compliance design, regulatory risk management and operational integrity across Medicare Advantage, Medicaid and other healthcare sectors.

What role will Sean O'Reilly have in FTI Consulting's Healthcare Risk Management & Advisory practice (FCN)?

Sean O'Reilly will advise clients on designing, implementing and improving enterprise compliance programs. According to FTI Consulting, he will focus on risk identification, control development and regulatory responsiveness for managed care and provider organizations in complex healthcare markets.

How will Sean O'Reilly use advanced analytics and AI at FTI Consulting (NYSE:FCN)?

Sean O'Reilly will support data-driven risk management using advanced analytics and artificial intelligence. According to FTI Consulting, his work will help identify and mitigate healthcare risks, including fraud, waste and abuse, by enhancing oversight across key compliance risk domains.

What is Sean O'Reilly's previous experience before joining FTI Consulting (FCN)?

Before joining FTI Consulting, Sean O'Reilly served as Senior Vice President and Chief Compliance Officer at a Fortune 50 integrated healthcare company. According to FTI Consulting, he led risk identification, remediation improvements and development of audit tools using advanced data analytics and natural language processing.

Why did FTI Consulting hire Sean O'Reilly for its healthcare risk and compliance team (FCN)?

FTI Consulting hired Sean O'Reilly for his blend of in-house leadership, regulatory experience and data analytics skills. According to FTI Consulting, this combination positions him to deliver value to clients facing complex healthcare compliance and high-stakes regulatory environments.

What healthcare sectors has Sean O'Reilly worked with before joining FTI Consulting (FCN)?

Sean O'Reilly has advised organizations in Medicare Advantage, Medicaid, employer group medical, specialty insurance and military healthcare. According to FTI Consulting, his background also spans hospice, home health, value-based primary care and pharmacy, covering a wide range of healthcare compliance needs.